Mayne Pharma Group (MAYNF) Receives a Buy from Canaccord Genuity
TipRanksSep. 22, 2024, 05:35 PMCanaccord Genuity analyst Elyse Shapiro maintained a Buy rating on Mayne Pharma Group (MAYNF – Research Report) on September 19 and set a price target of A$6.25. The company’s shares closed last Monday at $2.54.
Mayne Pharma Group (MAYNF) Receives a Buy from Canaccord...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.29 |
Change
0.070(1.34%) |
Mkt cap ! $429.7M | |||
| Open | High | Low | Value | Volume |
| $5.29 | $5.33 | $5.15 | $515.2K | 97.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 46 | $5.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.30 | 2184 | 23 |
View Market Depth
| Last trade - 15.46pm 18/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |